About Bulkamid
Bulkamid is a company based in London (United Kingdom) founded in 2003 was acquired by Axonics in February 2021. Bulkamid offers products and services including Bulkamid Hydrogel. Bulkamid operates in a competitive market with competitors including Axonics, Laborie Medical, Amber Therapeutics, NeuSpera Medical and UroMems, among others.
- Headquarter London, United Kingdom
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Axonics, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Bulkamid
Bulkamid offers a comprehensive portfolio of products and services, including Bulkamid Hydrogel.
Injectable hydrogel for managing stress urinary incontinence symptoms.
Funding Insights of Bulkamid
Detailed funding history for Bulkamid
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Bulkamid
Bulkamid has secured backing from 1 investor. Prominent investors backing the company include Axonics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Sacral neuromodulation devices are developed for urinary and bowel control.
|
Locked | Locked | Locked |
Investor details for Bulkamid
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bulkamid
Investment portfolio details for Bulkamid
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Bulkamid
Detailed financials for Bulkamid
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bulkamid Comparisons
Peer comparison for Bulkamid
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Bulkamid
Bulkamid operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Axonics, Laborie Medical, Amber Therapeutics, NeuSpera Medical and UroMems, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Sacral neuromodulation devices are developed for urinary and bowel control.
|
|
| Locked | Locked | Locked |
Medical products for female lower urinary tract dysfunctions are provided.
|
|
| Locked | Locked | Locked |
Bioelectrical therapies for peripheral nervous system disorders are developed.
|
|
| Locked | Locked | Locked |
Miniaturized injectable neuromodulation devices are developed for chronic diseases.
|
|
| Locked | Locked | Locked |
Developer of active implantable devices for urological incontinence
|
|
| Locked | Locked | Locked |
Non-invasive wearable devices for pelvic floor strengthening are developed.
|
Detailed competitors of Bulkamid
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bulkamid
Complete news archive for Bulkamid
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bulkamid
Bulkamid was founded in 2003.
Bulkamid is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Bulkamid was founded in 2003 and is based in London, United Kingdom. Operations focus on the medical sector, specifically urological treatments. A bulking agent is supplied for addressing stress urinary incontinence and bladder leaks in women. In-home treatment options are available, along with developed medications targeted at urinary issues during activities such as coughing, walking, or exercising. Services are directed toward normalizing these conditions factually.
Bulkamid's top competitors include Axonics, NeuSpera Medical and Laborie Medical.
Bulkamid offers Bulkamid Hydrogel.
Bulkamid has 1 investor. Key investors include Axonics.